What is Flownamics?
Flownamics specializes in the design and implementation of automated sampling systems and comprehensive bioprocess automation solutions. Their offerings are engineered to elevate accuracy and efficiency within the biotechnology industry, encompassing both upstream and downstream processes. The company's product portfolio features advanced technologies such as the Seg-Flow sampling systems, automated dispensing units, and biochemistry analyzers. With a legacy spanning over three decades, Flownamics is dedicated to advancing automation within scientific and industrial settings.
How much funding has Flownamics raised?
Flownamics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Flownamics
PPP
Public-Private Partnership
What's next for Flownamics?
The recent major strategic investment signals Flownamics' readiness for accelerated growth and market expansion. As a company with a long-standing history in bioprocess automation, this capital infusion is likely to fuel further research and development into next-generation sampling and automation technologies. Strategic deployment of these funds could enhance their competitive edge, broaden their client base, and solidify their role as a key player in optimizing laboratory and bioproduction workflows.
See full Flownamics company page
